Vestar MR 35 mg (Tablet (Modified Release))
Unit Price: ৳ 8.00 (3 x 10: ৳ 240.00)
Strip Price: ৳ 80.00
Medicine Details
Category | Details |
---|---|
Generic | Trimetazidine dihydrochloride |
Company | Healthcare pharmaceuticals ltd |
Indications
- Add-on therapy for stable angina pectoris
- Symptomatic treatment for inadequately controlled angina pectoris
Pharmacology
- First 3-keto acyl CoA thiolase inhibitor (KAT)
- Metabolic anti-ischemic agent
- Inhibits fatty acid pathway
- Transfers oxygen to glucose pathway
Dosage & Administration
- Recommended dose: 35 mg twice daily or 20 mg tablet thrice daily
- To be taken during meals
- Assess treatment response after three months
Interaction
- No reported drug interactions
- No known interaction with beta-blockers, calcium antagonists, nitrates, heparin, hypolipidemic agents, or digitalis preparation
Contraindications
- Hypersensitivity to the active substance or excipients
- Parkinson’s disease or related symptoms
- Severe renal impairment
Side Effects
- Dizziness
- Headache
- Abdominal pain
- Diarrhoea
- Dyspepsia
- Nausea
- Vomiting
- Rash
- Pruritus
- Urticaria
- Asthenia
Pregnancy & Lactation
- Preferable to avoid use during pregnancy
- Unknown excretion in human milk
- Risk to newborns/infants cannot be excluded
- Not to be used during breastfeeding
Precautions & Warnings
- Not a curative treatment for angina attacks
- Not an initial treatment for unstable angina pectoris
- Not a treatment for myocardial infarction
Therapeutic Class
- Other Anti-anginal & Anti-ischaemic drugs
Storage Conditions
- Keep in a dry place away from light and heat
- Keep out of the reach of children
Related Brands
- Trangina MR 35 mg (Tablet (Modified Release)) - biopharma-limited
- Anginox MR 35 mg (Tablet (Modified Release)) - general-pharmaceuticals-ltd
- Angitrim MR 35 mg (Tablet (Modified Release)) - globe-pharmaceuticals-ltd
- Trangit MR 35 mg (Tablet (Modified Release)) - sandoz-a-novartis-division
- Angivas MR 35 mg (Tablet (Modified Release)) - popular-pharmaceuticals-ltd